Funding
Funding not disclosed
Founders
Product
Problem
The biopharmaceutical industry faces challenges in sourcing high-performance, chemically defined cell culture media and formulation components. Traditional methods often rely on animal-derived materials, introducing variability, regulatory hurdles, and potential contamination risks. This impacts the efficiency and scalability of producing therapeutics like gene therapies, cell therapies, and vaccines.
Solution
InVitria provides a portfolio of recombinant, animal-origin-free proteins and cell culture supplements designed for chemically defined biomanufacturing and final formulation. Our products are engineered to enhance bioprocess efficiency, improve regulatory acceptance, and ensure supply chain reliability. By utilizing a proprietary plant-based expression system, we deliver consistent, high-purity components that mitigate the risks associated with animal-derived materials. This enables scalable and sustainable production of advanced therapeutics.
Target Audience
Our primary customers are biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), and research institutions involved in the development and production of biologics, cell therapies, gene therapies, and vaccines.
Features
- Recombinant Human Albumin (rHSA) products (e.g., Cellastim S®, Exbumin®, Optibumin®) for cell culture media optimization and viral vector stabilization, offering superior purity and low endotoxin levels.
- Recombinant Transferrin (e.g., Optiferrin®) for iron delivery in serum-free and reduced-serum culture applications, enhancing cell growth and transfection efficiency.
- Insulin-Transferrin-Selenium (ITS) supplements (e.g., ITS AF™, ITSE AF®) that are chemically defined and animal-origin-free, supporting cell proliferation and metabolic activity in serum-free media.
- Recombinant Human Lysozyme (e.g., Lysobac®) with enhanced antimicrobial activity for bacterial lysis in bioprocessing and food preservation, free from egg allergens.
- Chemically defined, blood-free cell culture media components and supplements manufactured in an ISO 9001:2015 certified facility.
- Scalable production capacity to meet metric ton demands for global distribution.
- Animal-origin-free (AOF) and blood-free formulations to meet stringent regulatory requirements and ethical sourcing standards.